LUNAR-101

N/A

Report date: 2023/01/08 10:16:33
NME

Base Information

Drug NameLUNAR-101
Drug Alias NameLUNAR-FIXLUNAR-HPNLUNAR-TPOLUNAR-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsAmyloidosisIron OverloadThrombocytopenia +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArcturus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyloidosisIron OverloadThrombocytopenia +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A